Novartis (NOVN.S) CEO Joe Jimenez will step down on Feb. 1 and hand over to drug development chief Vas Narasimhan to decide the fate of $50 billion in assets and make good on a pledge to return the Swiss company to sales growth. More »
The logo of Swiss pharmaceutical company Novartis is seen on its headquarters building in Basel, Switzerland October 27, 2015. REUTERS/Arnd Wiegmann Drugmaker Novartis (NOVN.S) is considering to sell its struggling Alcon eye care division, its chairman said in... More »
We use cookies!
By using this site you agree to the use of cookies, more info.